Scott Schlackman

Scott Schlackman, listed as board member, appears in our data through filings on Medifast Inc shares, published by SEC (Form 4). We count 16 filings; the first trade dates from 4 February 2016 and the latest from 25 June 2025.

In open-market terms, that means 5 purchases worth €9,840 on one side and 1 sale worth €230k on the other. Netting one side against the other leaves €220k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 8 share grants and 2 option exercises.

Half of the purchases are above €1,108 and half below. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

On 26 June 2025 came the latest disclosure, a share grant in Medifast Inc. The last insider purchase was made public on 9 November 2023, 1,074 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.